CompaniesCollgard Biopharmaceuticals

Collgard Biopharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

1,455

By Phase

PHASE3: 1PHASE1: 1

By Status

RECRUITING: 2ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
Today
NCT05947448
NCT06568471
Hover over trial bars to see details

Recent Trials

NCT06568471Lead Sponsor
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
PHASE3Recruiting
210 participants
Started: Nov 16, 2024 · Completed: May 31, 2026
NCT06504043Lead Sponsor
A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants
PHASE1Enrolling by invitation
30 participants
Started: Sep 17, 2024 · Completed: Mar 31, 2025
NCT05947448Lead Sponsor
Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study
N/ARecruiting
1,215 participants
Started: Jan 22, 2024 · Completed: Dec 31, 2025